FIELD: medicine. SUBSTANCE: invention relates to agents used in diagnosis of hemostasis pathology. Method involves mixing donor blood with preserving agent containing sodium citrate and sodium azide, plasma separation, combining plasma obtained from blood of separate donors and sublimating drying the plasma pool in the presence of N-(2-hydroxyethyl)-piperazine-N'-2-ethanesulfonic acid. Preserving agent has additionally glycine and aspartic acid or their mixture. N-(2-Hydroxyethyl)-piperazine-N'-2 -ethanesulfonic acid is added to plasma pool before sublimating drying in the amount 3.5-4.5 mg/1 ml of plasma. EFFECT: improved method of preparing, decreased consumption of N-(2- hydroxyethyl)-piperazine-N'-2-ethanesulfonic acid per 1 ml of plasma pool. 1 tbl, 3 ex
Title | Year | Author | Number |
---|---|---|---|
PRESERVING AGENT FOR WASHED OUT ERYTHROCYTES | 2002 |
|
RU2225692C2 |
METHOD FOR PREPARING REACTANT FOR SUBSEQUENT USE IN DETERMINING ACTIVATED PARTIAL THROMBOPLASTINOPOIESIS TIME | 1995 |
|
RU2104551C1 |
METHOD FOR PRODUCTION OF CONTROL PLASMA WITH NORMAL LEVEL OF PROTHROMBIN COMPLEX | 2004 |
|
RU2270020C2 |
METHOD OF PREPARING THE PRESERVING AGENT FOR ERYTHROCYTES | 1995 |
|
RU2098959C1 |
METHOD OF DIAGNOSTICUM PREPARING FOR CONTROL OVER ANTICOAGULANT THERAPY | 1991 |
|
RU2013778C1 |
METHOD OF PREPARING IMMUNOGLOBULIN FOR INTRAVENOUS ADMINISTRATION | 1992 |
|
RU2068695C1 |
BLOOD SUBSTITUTE AS OXYGEN TRANSPORTER, COMPOSITION FOR ITS PREPARING AND METHOD OF POLYMERIC MODIFIED HEMOGLOBIN PREPARING | 1999 |
|
RU2162707C2 |
METHOD OF REAGENT PREPARING FOR DETERMINATION OF ACTIVATED PARTIAL THROMBOPLASTIN TIME | 1990 |
|
RU1767743C |
POLYFUNCTIONAL BLOOD SUBSTITUTE FOR TREATMENT OF BLOOD LOSS AND SHOCK | 1998 |
|
RU2136291C1 |
ADDITIONAL SOLUTION FOR STORAGE OF THROMBOCYTE CONCENTRATE | 2019 |
|
RU2720487C1 |
Authors
Dates
2001-10-20—Published
2000-06-06—Filed